Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemo-embolization with mitomycin C microcapsules for hepatoma].

T Kato, Y Tamakawa, K Unno

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |April 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

    Nature communications·2020
    Same author

    Chloroplast development in Arabidopsis thaliana requires the nuclear-encoded transcription factor sigma B.

    FEBS letters·2000
    Same author

    Increase in basal level of Hsp70, consisting chiefly of constitutively expressed Hsp70 (Hsc70) in aged rat brain.

    The journals of gerontology. Series A, Biological sciences and medical sciences·2000
    Same author

    RT-PCR suggests human skeletal muscle origin of alveolar soft-part sarcoma.

    Oncology·2000
    Same author

    Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury.

    Kidney international·1999
    Same author

    Effect of over-expressed hsp26 on cell growth of yeast.

    Biological & pharmaceutical bulletin·1998

    Mitomycin C microcapsules (MMC-mc) offer effective chemo-embolization for advanced liver tumors. This novel drug carrier demonstrated significant tumor reduction and improved survival rates in patients.

    Area of Science:

    • Oncology
    • Pharmacology
    • Interventional Radiology

    Background:

    • Advanced hepatoma presents significant treatment challenges.
    • Novel drug delivery systems are needed to improve therapeutic efficacy and reduce systemic toxicity.
    • Chemo-embolization is a promising regional therapy for liver tumors.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Mitomycin C microcapsules (MMC-mc) for intra-arterial chemo-embolization in patients with advanced hepatoma.
    • To compare the therapeutic effect of MMC-mc chemo-embolization with traditional arterial chemotherapy and embolization techniques.

    Main Methods:

    • Sixty-seven patients with advanced hepatoma received intra-arterial MMC-mc infusions.
    • Treatment involved single or multiple infusions of an average dose of 20 mg MMC-mc.

    Related Experiment Videos

  • Tumor response was assessed by objective tumor reduction and changes in serum alpha-fetoprotein levels.

    • Main Results:

    • Objective tumor reduction (>25% area) was observed in 40% of measurable tumors.
    • Serum alpha-fetoprotein levels improved in 85% of treated patients.
    • Relative 6-month and 12-month survival rates were 49% and 26%, respectively, in patients without distant metastasis.

    Conclusions:

    • Mitomycin C microcapsules (MMC-mc) demonstrate potential as an effective palliative and preoperative treatment for liver tumors.
    • The chemo-embolization approach with MMC-mc offers significant tumor reduction and survival benefits.
    • Further controlled clinical trials are warranted to fully establish the advantages of MMC-mc in liver cancer treatment.